[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337025-105":59,"doc-detail-337025-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-exon-junction-complex-component-eif4a3-plays-a-splicing-linked-oncogenic-role-in-pancreatic-ductal-adenocarcinoma","The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma","","Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer, driving the need for deeper biological research and improved diagnostic and therapeutic strategies. Dysregulated alternative RNA splicing is a common cancer hallmark, including in PDAC. This study investigates EIF4A3, a core Exon Junction Complex component linked to RNA splicing. EIF4A3 is overexpressed in PDAC tissues, correlating with malignancy parameters and poorer survival. Functional experiments show that EIF4A3 modulation impairs tumor proliferation, migration, and growth, and RNA-seq reveals widespread transcriptional and spliceosomic changes consistent with RNA homeostasis regulation. The findings support EIF4A3 as a potential biomarker and actionable target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-exon-junction-complex-component-eif4a3-plays-a-splicing-linked-oncogenic-role-in-pancreatic-ductal-adenocarcinoma/337025/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-exon-junction-complex-component-eif4a3-plays-a-splicing-linked-oncogenic-role-in-pancreatic-ductal-adenocarcinoma/337025.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main biological focus of the study?","Question",{"text":112,"@type":113},"The study focuses on EIF4A3, a component of the Exon Junction Complex, and its splicing-linked oncogenic role in pancreatic ductal adenocarcinoma (PDAC).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does EIF4A3 relate to PDAC clinical outcomes?",{"text":117,"@type":113},"EIF4A3 is overexpressed in PDAC tissues and is associated with clinical parameters of malignancy and poorer patient survival.",{"name":119,"@type":110,"acceptedAnswer":120},"What happens to tumor-related functions when EIF4A3 is targeted in experiments?",{"text":121,"@type":113},"In vitro EIF4A3 targeting reduces key tumor features such as proliferation, migration, and colony/sphere formation, while in vivo targeting decreases tumor growth.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337025,1790866874,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.nature.com/cgt](www.nature.com/cgt) Cancer Gene Therapy  \nARTICLE OPEN   \nThe Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductaladenocarcinoma  \nRicardo Blázquez-Encinas 1,2,3, Emilia Alors-Pérez 1,2,3, María Trinidad Moreno-Montilla 1,2,3, Víctor García-Vioque 1,2,3,  \nMarina Esther Sánchez-Frías 1,3,4, Andrea Mafﬁcini5,6, Juan L. López-Cánovas 1,2,3, Corinne Bousquet7, Manuel D. Gahete 1,2,3,8, Rita T. Lawlor5,6, Raúl M. Luque 1,2,3,8, Aldo Scarpa6,9, Álvaro Arjona‐Sánchez1,3,10, Sergio Pedraza-Arevalo1,2,3,  \nAlejandro Ibáñez-Costa 1,2,3,11 ✉ and Justo P. Castaño 1,2,3,8,11 ✉  \n© The Author(s) 2024  \n\n|  | Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, underscoring the urgent need for in-depth biological research. The phenomenon of alternative RNA splicing dysregulation is a common hallmark in cancer, including PDAC, presenting new avenues for understanding and developing diagnostic and therapeutic tools. Our research focuses on EIF4A3, a core component of the Exon Junction Complex intimately linked to RNA splicing, and its role in PDAC. EIF4A3 is overexpressed in PDACtissue and associated to clinical parameters of malignancy and poorer patient survival. Mechanistically, exploration of PDAC RNAseq data unveiled the link of EIF4A3 to diverse malignancy processes, consistent with its association to key molecular pathways. EIF4A3 targeting in vitro decreased essential functional tumor features such as proliferation, migration, colony formation and sphere formation, while its in vivo targeting reduced tumor growth. EIF4A3 silencing in PDAC cell lines severely altered its transcriptional and spliceosomic landscapes, as shown by RNA-seq analyses, suggesting a role for EIF4A3 in maintaining RNA homeostasis. Our results indicate that EIF4A3 dysregulation in PDAC has a pleiotropic regulatory role on RNA biology, inﬂuencing key cellular functions. This paves the way to explore its potential as novel biomarker and actionable target candidate for this lethal |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| cancer. |  |  |\n|  | Cancer Gene Therapy (2024) 31:1646–1657; [https://doi.org/10.1038/s41417-024-00814-3](https://doi.org/10.1038/s41417-024-00814-3) |  |\n|  |  |  |\n\nINTRODUCTION  \nPancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers worldwide, mostly due to its late diagnosis—often with metastasis—and current lack of effective treatments, jointly leading to poor prognosis [1–3] . Research advances on PDAC molecular biology have established the primary pathologic relevance of the most frequently mutated genes: KRAS, TP53, CDKN2A and SMAD4 [1, 2] . However, the knowledge gathered to date cannot fully explain the molecular underpinnings of the disease, and its present translation into clinical beneﬁts for the patients is still lagging [2, 4–6] . Hence, novel research avenues are sorely required to ﬁnd new molecular players that facilitate a better understanding of PDAC and provide new biomarkers and therapeutic targets to tackle this pathology. In this vein, studies from our group and others have shown that dysregulation of RNA splicing plays a key role in PDAC, which leverages this still limitedly known mechanism as a source of novel molecular tools [7–12] .  \nSplicing is a process of RNA maturation that occurs cotranscriptionally, by which introns are removed from pre-RNA and exons are joined together [13] . This process is ﬁnely regulated to enable the generation of different mature RNA variants, or isoforms, from the same gene, which can then give rise to different proteins, or to mature non-translated RNAs [14], thereby increasing the diversity and versatility of the genome. Alternative splicing is therefore a capital step within the central dogma of Biology (DNA-> RNA-> protein) and its dysregulation is linked to the appearan","cbCaitoNenpK0NqQ","https://ap.wps.com/l/cbCaitoNenpK0NqQ","pdf",4754339,12,"English","# Introduction","[{\"question\":\"What is the main biological focus of the study?\",\"answer\":\"The study focuses on EIF4A3, a component of the Exon Junction Complex, and its splicing-linked oncogenic role in pancreatic ductal adenocarcinoma (PDAC).\"},{\"question\":\"How does EIF4A3 relate to PDAC clinical outcomes?\",\"answer\":\"EIF4A3 is overexpressed in PDAC tissues and is associated with clinical parameters of malignancy and poorer patient survival.\"},{\"question\":\"What happens to tumor-related functions when EIF4A3 is targeted in experiments?\",\"answer\":\"In vitro EIF4A3 targeting reduces key tumor features such as proliferation, migration, and colony/sphere formation, while in vivo targeting decreases tumor growth.\"}]","The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma | PDF",1790017433,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a83d014f7c67e5fb563fa04d396bb131.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/874dd8dcedf3babf8cc7edfd57461577.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86855b99eaaa866b1f427e864ccf4e3b.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f1f3b2bc8ca65ad7919ad85f86388b2.webp",980,1301]